Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the NK Cell Therapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc (USA)
Innate Pharma SA (France)
NantKwest Inc (USA)
Altor BioScience Corporation (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)
Affimed NV (Netherlands)
Chipscreen Biosciences (China)
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Mogamulizumab
Lorvotuzumab Mertansine
Others
Application:
Cancer
Cardiovascular Diseases
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 NK Cell Therapy Industry Overview
-
1.1.1 NK Cell Therapy Market Scope and Market Segments
-
1.1.2 NK Cell Therapy Industry Characteristics
-
1.1.3 Global and China NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China NK Cell Therapy Production Value and Growth Rate (2017-2028)
-
1.2 Global NK Cell Therapy Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Mogamulizumab
-
1.2.2 Lorvotuzumab Mertansine
-
1.2.3 Others
-
1.3 Global NK Cell Therapy Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Cancer
-
1.3.2 Cardiovascular Diseases
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America NK Cell Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe NK Cell Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC NK Cell Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa NK Cell Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global NK Cell Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global NK Cell Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China NK Cell Therapy Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China NK Cell Therapy Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global NK Cell Therapy Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 NK Cell Therapy Industry Porter's Five Forces Model Analysis
-
2.2.3 NK Cell Therapy Industry PEST Analysis
-
2.3 NK Cell Therapy Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 NK Cell Therapy Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on NK Cell Therapy Industry
Chapter 3 Global and China NK Cell Therapy Market, by Manufacturer
-
3.1 Global and China NK Cell Therapy Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China NK Cell Therapy Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China NK Cell Therapy Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China NK Cell Therapy Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China NK Cell Therapy Market Top 3 Players
Chapter 4 Global and China NK Cell Therapy Market, by Type (2017-2028)
-
4.1 NK Cell Therapy Market Trend, by Type
-
4.2 Global NK Cell Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global NK Cell Therapy Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global NK Cell Therapy Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global NK Cell Therapy Price Trend, by Type (2017-2028)
-
4.3 China NK Cell Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China NK Cell Therapy Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China NK Cell Therapy Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China NK Cell Therapy Price Trend, by Type (2017-2028)
Chapter 5 Global and China NK Cell Therapy Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global NK Cell Therapy Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global NK Cell Therapy Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global NK Cell Therapy Sales Value and Market Share, by Application (2017-2028)
-
5.3 China NK Cell Therapy Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China NK Cell Therapy Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China NK Cell Therapy Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global NK Cell Therapy Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China NK Cell Therapy Production, Import, Consumption and Export (2017-2022)
-
6.2 North America NK Cell Therapy Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe NK Cell Therapy Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC NK Cell Therapy Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa NK Cell Therapy Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America NK Cell Therapy Market Analysis
-
7.1 North America NK Cell Therapy Market, by Type
-
7.2 North America NK Cell Therapy Market, by Application
-
7.3 North America NK Cell Therapy Market Analysis and Forecast, by Country
-
7.3.1 United States NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe NK Cell Therapy Market Analysis
-
8.1 Europe NK Cell Therapy Market, by Type
-
8.2 Europe NK Cell Therapy Market, by Application
-
8.3 Europe NK Cell Therapy Market Analysis and Forecast, by Country
-
8.3.1 Germany NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC NK Cell Therapy Market Analysis
-
9.1 APAC NK Cell Therapy Market, by Type
-
9.2 APAC NK Cell Therapy Market, by Application
-
9.3 APAC NK Cell Therapy Market Analysis and Forecast, by Country
-
9.3.1 China NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa NK Cell Therapy Market Analysis
-
10.1 Latin America, Middle East and Africa NK Cell Therapy Market, by Type
-
10.2 Latin America, Middle East and Africa NK Cell Therapy Market, by Application
-
10.3 Latin America, Middle East and Africa NK Cell Therapy Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina NK Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China NK Cell Therapy Company Profiles
-
11.1 Takeda Pharmaceutical (Japan)
-
11.1.1 Takeda Pharmaceutical (Japan) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Takeda Pharmaceutical (Japan) NK Cell Therapy Product Profiles, Application and Specification
-
11.1.3 Takeda Pharmaceutical (Japan) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Sorrento Therapeutics Inc (USA)
-
11.2.1 Sorrento Therapeutics Inc (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Sorrento Therapeutics Inc (USA) NK Cell Therapy Product Profiles, Application and Specification
-
11.2.3 Sorrento Therapeutics Inc (USA) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Innate Pharma SA (France)
-
11.3.1 Innate Pharma SA (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Innate Pharma SA (France) NK Cell Therapy Product Profiles, Application and Specification
-
11.3.3 Innate Pharma SA (France) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 NantKwest Inc (USA)
-
11.4.1 NantKwest Inc (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 NantKwest Inc (USA) NK Cell Therapy Product Profiles, Application and Specification
-
11.4.3 NantKwest Inc (USA) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Altor BioScience Corporation (USA)
-
11.5.1 Altor BioScience Corporation (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Altor BioScience Corporation (USA) NK Cell Therapy Product Profiles, Application and Specification
-
11.5.3 Altor BioScience Corporation (USA) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Bristol-Myers Squibb (USA)
-
11.6.1 Bristol-Myers Squibb (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Bristol-Myers Squibb (USA) NK Cell Therapy Product Profiles, Application and Specification
-
11.6.3 Bristol-Myers Squibb (USA) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 NKT Therapeutics (USA)
-
11.7.1 NKT Therapeutics (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 NKT Therapeutics (USA) NK Cell Therapy Product Profiles, Application and Specification
-
11.7.3 NKT Therapeutics (USA) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Affimed NV (Netherlands)
-
11.8.1 Affimed NV (Netherlands) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Affimed NV (Netherlands) NK Cell Therapy Product Profiles, Application and Specification
-
11.8.3 Affimed NV (Netherlands) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Chipscreen Biosciences (China)
-
11.9.1 Chipscreen Biosciences (China) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Chipscreen Biosciences (China) NK Cell Therapy Product Profiles, Application and Specification
-
11.9.3 Chipscreen Biosciences (China) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 NK Cell Therapy Industry Investment Prospect and Risk Assessment
-
12.1 NK Cell Therapy Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 NK Cell Therapy Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure China NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Global NK Cell Therapy Production Value and Growth Rate (2017-2028)
-
Figure China NK Cell Therapy Production Value and Growth Rate (2017-2028)
-
Figure Global NK Cell Therapy Market Size and Growth Rate of Mogamulizumab (2017-2028)
-
Figure Global NK Cell Therapy Market Size and Growth Rate of Lorvotuzumab Mertansine (2017-2028)
-
Figure Global NK Cell Therapy Market Size and Growth Rate of Others (2017-2028)
-
Figure Global NK Cell Therapy Market Size and Growth Rate of Cancer (2017-2028)
-
Figure Global NK Cell Therapy Market Size and Growth Rate of Cardiovascular Diseases (2017-2028)
-
Figure Global NK Cell Therapy Market Size and Growth Rate of Others (2017-2028)
-
Figure North America NK Cell Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe NK Cell Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC NK Cell Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa NK Cell Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global NK Cell Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China NK Cell Therapy Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China NK Cell Therapy Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China NK Cell Therapy Sales Value, by Manufacturer (2021&2022)
-
Table Global and China NK Cell Therapy Market Share, by Manufacturer (2021&2022)
-
Figure Global and China NK Cell Therapy Market Share, by Manufacturer in 2021
-
Figure Global and China NK Cell Therapy Market Share, by Manufacturer in 2022
-
Table Global NK Cell Therapy Sales Volume, by Type (2017-2028)
-
Table Global NK Cell Therapy Sales Volume Share, by Type (2017-2028)
-
Figure Global NK Cell Therapy Sales Volume Share, by Type (2017-2028)
-
Table Global NK Cell Therapy Sales Value, by Type (2017-2028)
-
Table Global NK Cell Therapy Sales Value Share, by Type (2017-2028)
-
Figure Global NK Cell Therapy Price Trend, by Type (2017-2028)
-
Table China NK Cell Therapy Sales Volume, by Type (2017-2028)
-
Table China NK Cell Therapy Sales Volume Share, by Type (2017-2028)
-
Figure China NK Cell Therapy Sales Volume Share, by Type (2017-2028)
-
Table China NK Cell Therapy Sales Value, by Type (2017-2028)
-
Table China NK Cell Therapy Sales Value Share, by Type (2017-2028)
-
Figure China NK Cell Therapy Price Trend, by Type (2017-2028)
-
Table Global NK Cell Therapy Sales Volume, by Application (2017-2028)
-
Table Global NK Cell Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Global NK Cell Therapy Sales Volume Share, by Application (2017-2028)
-
Table Global NK Cell Therapy Sales Value, by Application (2017-2028)
-
Table Global NK Cell Therapy Sales Value Share, by Application (2017-2028)
-
Figure Global NK Cell Therapy Sales Value Share, by Application (2017-2028)
-
Table China NK Cell Therapy Sales Volume, by Application (2017-2028)
-
Table China NK Cell Therapy Sales Volume Share, by Application (2017-2028)
-
Figure China NK Cell Therapy Sales Volume Share, by Application (2017-2028)
-
Table China NK Cell Therapy Sales Value, by Application (2017-2028)
-
Table China NK Cell Therapy Sales Value Share, by Application (2017-2028)
-
Figure China NK Cell Therapy Sales Value Share, by Application (2017-2028)
-
Figure China NK Cell Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure North America NK Cell Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure Europe NK Cell Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure APAC NK Cell Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa NK Cell Therapy Production, Import, Consumption and Export (2017-2022)
-
Table North America NK Cell Therapy Sales Volume, by Type (2017-2028)
-
Table North America NK Cell Therapy Sales Volume Share, by Type (2017-2028)
-
Figure North America NK Cell Therapy Sales Volume Share, by Type (2017-2028)
-
Table North America NK Cell Therapy Sales Volume, by Application (2017-2028)
-
Table North America NK Cell Therapy Sales Volume Share, by Application (2017-2028)
-
Figure North America NK Cell Therapy Sales Volume Share, by Application (2017-2028)
-
Figure United States NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure United States NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Canada NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Canada NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Mexico NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Table Europe NK Cell Therapy Sales Volume, by Type (2017-2028)
-
Table Europe NK Cell Therapy Sales Volume Share, by Type (2017-2028)
-
Figure Europe NK Cell Therapy Sales Volume Share, by Type (2017-2028)
-
Table Europe NK Cell Therapy Sales Volume, by Application (2017-2028)
-
Table Europe NK Cell Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Europe NK Cell Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Germany NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Germany NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure UK NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure UK NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure France NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure France NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Italy NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Italy NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Spain NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Spain NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Belgium NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Poland NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Poland NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Russia NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Russia NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Turkey NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Table APAC NK Cell Therapy Sales Volume, by Type (2017-2028)
-
Table APAC NK Cell Therapy Sales Volume Share, by Type (2017-2028)
-
Figure APAC NK Cell Therapy Sales Volume Share, by Type (2017-2028)
-
Table APAC NK Cell Therapy Sales Volume, by Application (2017-2028)
-
Table APAC NK Cell Therapy Sales Volume Share, by Application (2017-2028)
-
Figure APAC NK Cell Therapy Sales Volume Share, by Application (2017-2028)
-
Figure China NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure China NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Japan NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Japan NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure India NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure India NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure South Korea NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa NK Cell Therapy Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa NK Cell Therapy Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa NK Cell Therapy Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa NK Cell Therapy Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa NK Cell Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa NK Cell Therapy Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Brazil NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure South Africa NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Argentina NK Cell Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina NK Cell Therapy Sales Value and Growth Rate (2017-2028)
-
Table Takeda Pharmaceutical (Japan) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Takeda Pharmaceutical (Japan) Product Profiles, Application and Specification
-
Table Takeda Pharmaceutical (Japan) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sorrento Therapeutics Inc (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sorrento Therapeutics Inc (USA) Product Profiles, Application and Specification
-
Table Sorrento Therapeutics Inc (USA) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Innate Pharma SA (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Innate Pharma SA (France) Product Profiles, Application and Specification
-
Table Innate Pharma SA (France) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table NantKwest Inc (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table NantKwest Inc (USA) Product Profiles, Application and Specification
-
Table NantKwest Inc (USA) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Altor BioScience Corporation (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Altor BioScience Corporation (USA) Product Profiles, Application and Specification
-
Table Altor BioScience Corporation (USA) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb (USA) Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb (USA) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table NKT Therapeutics (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table NKT Therapeutics (USA) Product Profiles, Application and Specification
-
Table NKT Therapeutics (USA) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Affimed NV (Netherlands) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Affimed NV (Netherlands) Product Profiles, Application and Specification
-
Table Affimed NV (Netherlands) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Chipscreen Biosciences (China) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Chipscreen Biosciences (China) Product Profiles, Application and Specification
-
Table Chipscreen Biosciences (China) NK Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
